That statement confused me too. I suspect you're right, that the working cap facility allowed them to fill back orders and stock sufficient inventory, and from now on they will only need to top up their inventory as required.
The Sep quarter had production costs of $214k, the Dec quarter shot up to $743k, and now the March quarter is projecting $382k.
As I'm sure management have no intention of reducing sales, their inventory must now be well and truly stocked to comfortably meet demand without maintaining that significant production expense in the December quarter.
SCT Price at posting:
16.0¢ Sentiment: Buy Disclosure: Held
(20min delay)